Enhanced susceptibility to foodborne infections and disease due to underlying illnesses and pregnancy

Food Consumption and Disease Risk: Consumer-Pathogen Interactions

Volumn , Issue , 2006, Pages 233-247

  Kobayashi, J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903417923     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845692025.2.233     Document Type: Chapter

References (52)

1. Angulo F.J., Swerdlow D.L. Bacterial enteric infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995, 21(Suppl 1):S84-93.
2. Atherton J.C., Blaser M.J. Helicobacter pylori infections. Harrison's Principles of Internal Medicine 2005, McGraw-Hill, New York, Chapter 135. 16. D.L. Kasper, E. Braunwald, A.S. Fauci (Eds.).
3. Banatvala N., Cramp A., Jones I.R., Feldman R.A. Salmonellosis in North Thames (East), UK: associated risk factors. Epidemiol Infect 1999, 122:201-207.
4. Barton J.C., Coghlan M.E., Reymann M.T., Ozbirn T.W., Acton R.T. Vibrio vulnificus infection in a hemodialysis patient receiving intravenous iron therapy. Clin Infect Dis 2003, 37:e63-e67.
5. Bisharat N., Agmon V., Finkelstein R., et al. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteremia in Israel. Lancet 1999, 354:1421-1424.
6. Blake P.A., Merson M.H., Weaver R.E., Hollis D.G., Heublein P.C. Disease caused by a marine Vibrio. N Eng J Med 1979, 300:1-5.
7. Bowie W.R., King A.S., Werkerdh, et al. Outbreak of toxoplasmosis associated with municipal drinking water. Lancet 1997, 350:173-177.
8. Boyer K.M., Holfels E., Roizenn Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstetrics Gynecology 2005, 192:564-571.
9. CCR California Code of Regulations 2003, Title 17, Sections 13675 and 13676 'Limiting the Sale of Raw Gulf Coast Oysters in California'. http://www.dhs.ca.gov/ps/fdb/HTML/Food/indexfoo.htm.
10. CDC (Centers For Disease Control And Prevention) Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. Morb Mortal Wkly Rep 1997, 46:165-173.
11. CDC HIV/AIDS Surveillance Report, 2003 2004, DHHS, Atlanta, 15, Tables 3 and 10.
12. CDC National Program of Cancer Registries 2005, http://www.cdc.gov/cancer/npcr/.
13. Celum C.L., Chaisson R.E., Rutherford G.W., et al. Incidence of salmonellosis in patients with AIDS. J Infect Dis 1987, 156:998-1002.
14. Cook A.J.C., Gilbert R.E., Buffolano W., Zufferey E., et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. BMJ 2000, 321:142-147.
15. Del Valle J. Peptic ulcer disease and related disorders. Harrison's Principles of Internal Medicine 2005, McGraw-Hill, New York, Chapter 274. 16. D.L. Kasper, E. Braunwald, A.S. Fauci (Eds.).
16. FDA Food and Drug Administration, Center for Food Safety and Applied Nutrition, National Shellfish Sanitation Program. Guide for Control of Molluscan Shellfish, 2003 2003.
17. FSIS Verification Procedures for the Listeria monocytogenes Regulation and Microbial Sampling of Ready-to-Eat (RTE) Products for the FSIS Verification Testing Program 2003, US Department of Agriculture, Food Safety and Inspection Service, FSIS Directive, 10,240.4, 10/2/03. http://www.fsis.usda.gov/OPPDE/rdad/FSISDirectives/10240-4.pdf.
18. Gilks C.F. Prophylaxis for HIV-associated infections in the developing world. J Antimicrob Chemother 1993, 31(suppl B):119-128.
19. Graves L.M., Swaminathan B. PulseNet standardized protocol for subtyping Listeria monocytogenes by macrorestriction and pulsed-field gel electrophoresis. Int J Food Microbiol 2001, 65:55-62.
20. Gruenwald R., Blum S., Chan J. Relationship between human immunodeficiency virus infection and salmonellosis in 20- to 59-year-old residents of New York City. Clin Infecti Dis 1994, 18:358-363.
21. Heymann D.L. Control of Communicable Diseases Manual 2004, American Public Health Association, Washington DC. 18th Edition.
22. Ho J.L., Shands K.N., Friedland P., et al. An outbreak of type 4b Listeria monocytogenes involving patients from eight Boston hospitals. Arch Intern Med 1986, 146:520-524.
23. Hor L.I., Chang Y.K., Chang C.C., Lei H.Y., Ou J.T. Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection. Microbiol Immunol 2000, 44:871-878.
24. Jones J.L., Hanson D.L., Dworkin M.S., et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. CDC Surveillance Summaries, MMWR Morb Mortal Wkly Rep 1999, 48:1-22. SS-2.
25. Kaplan J., Hanson D., Dworkin M.S., et al. Epidemiology of Human Immunodeficiency Virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000, 30:S5-14.
26. Kennedy M., Villar R., Vugia D.J., et al. Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999. CID 2004, 38(Suppl 3):S142-148.
27. Kravetz J.D., Federman D.G. Toxoplasmosis in pregnancy. Amer J Med 2005, 118(3):212-216.
28. Lopez A., Dietz V.J., Wilson M., et al. 'Preventing congenital toxoplasmosis' Centers for Disease Control and Prevention. CDC Recommendations Regarding Selected Conditions Affecting Women's Health. MMWR 2000, 49(No. RR-2):59-75.
29. Lorberb Listeria monocytogenes. Principles and Practice of Infectious Diseases 2000, 2208-2215. Churchill Livingstone, New York, Chapter 195,. 5th Edition. G.H. Mandell, J.E. Bennett, R. Donlin (Eds.).
30. Martinsen T.C., Bergh K., Waldrum H.L. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol 2005, 96:94-102.
31. Matsui T., Ono T., Inuoue Y. An outbreak of Vibrio vulnificus infection in Kumamoto, Japan, 2001. Arch Dermatol 2004, 140:888-889.
32. MMWR Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 sites, United States, 2004. Morb Mortal Wkly Rep. 2005, 54(14):352-356.
33. Morris J.G., Potter M. Emergence of new pathogens as a function of changes in host susceptibility. Emerging Infect Dis 1997, 3(4):435-441.
34. Mylonakis E., Paliou M., Hohmann E.L., et al. Listeriosis during pregnancy - a case series and review of 222 cases. Medicine 2002, 81(4):260-269.
35. National Center For Health Statistics Health, United States, 1996-97 and Injury Chartbook 1997, Center for Health Statistics, Hyattsville, MD.
36. National Center For Health Statistics Health, United States, 2004 2004, Center for Health Statistics, Hyattsville, MD, Tables 53 and 54.
37. National Institute For Health Care Management Prescription drug expenditures in 2001: another year of escalating costs 2002, NIHCM Foundation, Washington DC, available online at. http://www.nihcm.org.
38. Neal K.R., Scott H.M., Slack R.C.B., Logan R.F.A. Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study. BMJ 1996, 312(7028):414-415.
39. Olsen S.J., Patrick M., Hunter S.B., et al. Multistate outbreak of Listeria monocytogenes infection linked to delicatessen turkey meat. CID 2005, 40:962-967.
40. Organ Procurement And Transplantation Network http://www.optn.org/data.
41. Rodriguez L.A.G., Ruigomez A. Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk?. Epidemiology 1997, 8(5):571-574.
42. Roghmann M.C., Faulkner C.T., Lefkowitz A., Patton S., et al. Decreased seropreualence for Toxoplasma gondil in Seventh Day Adventists in Maryland. Am J Trop Med Hyg 1999, 60:790-792.
43. Schlech W.F., Lavigne P.M., Bortolussi R.A., et al. Epidemic listeriosis; evidence for transmission by food. N Engl J Med 1983, 308:203-206.
44. Schuchat A., Deaver K.A., Wenger J.D., et al. Role of foods in sporadic listeriosis. JAMA 1992, 267(15):2041-2045.
45. Shapiro R.L., Altekruse S., Hutwagner L., et al. The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. J Infec Dis 1998, 178:752-759.
46. Smith J.L. Foodborne infections during pregnancy. J Food Prot 1999, 62(7):818-829.
47. Smith J.L. The role of gastric acid in preventing foodborne disease and how bacteria overcome acid conditions. J Food Protec 2003, 66(7):1292-1303.
48. Sperber S.J., Schleupner C.J. Salmonellosis during infection with human immunodeficiency virus. Rev Inf Dis 1987, 9:925-934.
49. Swaminathan B., Barrett T., Hunter S.B., Tauxe R.V., et al. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis 2001, 7(3):382-389.
50. Vella S., Palmisano L. The global status of resistance to antiretroviral drugs. Clin Infect Dis 2005, 41:s239-s246.
51. Vugia D.J., Kiehlbauch J.A., Yeboue K., et al. Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, West Africa. J Infect Dis 1993, 168:564-570.
52. Wright A.C., Simpson L.M., Oliver J.D. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun 1981, 34:503-507.